Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 3
1998 2
1999 1
2000 2
2001 2
2002 2
2004 3
2005 4
2006 2
2007 4
2008 3
2009 3
2010 1
2011 6
2012 3
2013 6
2014 8
2015 9
2016 7
2017 7
2018 7
2019 8
2020 4
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Results by year
Filters applied: . Clear all
Page 1
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. Delmore JE, et al. Among authors: chesi m. Cell. 2011 Sep 16;146(6):904-17. doi: 10.1016/j.cell.2011.08.017. Epub 2011 Sep 1. Cell. 2011. PMID: 21889194 Free PMC article.
Dysregulated IL-18 Is a Key Driver of Immunosuppression and a Possible Therapeutic Target in the Multiple Myeloma Microenvironment.
Nakamura K, Kassem S, Cleynen A, Chrétien ML, Guillerey C, Putz EM, Bald T, Förster I, Vuckovic S, Hill GR, Masters SL, Chesi M, Bergsagel PL, Avet-Loiseau H, Martinet L, Smyth MJ. Nakamura K, et al. Among authors: chesi m. Cancer Cell. 2018 Apr 9;33(4):634-648.e5. doi: 10.1016/j.ccell.2018.02.007. Cancer Cell. 2018. PMID: 29551594 Free article.
V. Molecular classification and risk stratification of myeloma.
Bergsagel PL, Chesi M. Bergsagel PL, et al. Among authors: chesi m. Hematol Oncol. 2013 Jun;31 Suppl 1(0 1):38-41. doi: 10.1002/hon.2065. Hematol Oncol. 2013. PMID: 23775647 Free PMC article. Review. No abstract available.
MYC dysregulation in the progression of multiple myeloma.
Misund K, Keane N, Stein CK, Asmann YW, Day G, Welsh S, Van Wier SA, Riggs DL, Ahmann G, Chesi M, Viswanatha DS, Kumar SK, Dispenzieri A, Gonzalez-Calle V, Kyle RA, O'Dwyer M, Rajkumar SV, Kortüm KM, Keats JJ; MMRF CoMMpass Network, Fonseca R, Stewart AK, Kuehl WM, Braggio E, Bergsagel PL. Misund K, et al. Among authors: chesi m. Leukemia. 2020 Jan;34(1):322-326. doi: 10.1038/s41375-019-0543-4. Epub 2019 Aug 22. Leukemia. 2020. PMID: 31439946 Free PMC article. No abstract available.
Many multiple myelomas: making more of the molecular mayhem.
Chesi M, Bergsagel PL. Chesi M, et al. Hematology Am Soc Hematol Educ Program. 2011;2011:344-53. doi: 10.1182/asheducation-2011.1.344. Hematology Am Soc Hematol Educ Program. 2011. PMID: 22160056 Free PMC article. Review.
Antibodies Create Killer Bonds in Myeloma.
Chesi M, Fonseca R. Chesi M, et al. Cancer Cell. 2017 Mar 13;31(3):305-307. doi: 10.1016/j.ccell.2017.02.011. Cancer Cell. 2017. PMID: 28292432 Free article.
Antigen-mediated regulation in monoclonal gammopathies and myeloma.
Nair S, Sng J, Boddupalli CS, Seckinger A, Chesi M, Fulciniti M, Zhang L, Rauniyar N, Lopez M, Neparidze N, Parker T, Munshi NC, Sexton R, Barlogie B, Orlowski R, Bergsagel L, Hose D, Flavell RA, Mistry PK, Meffre E, Dhodapkar MV. Nair S, et al. Among authors: chesi m. JCI Insight. 2018 Apr 19;3(8):e98259. doi: 10.1172/jci.insight.98259. eCollection 2018 Apr 19. JCI Insight. 2018. PMID: 29669929 Free PMC article. Clinical Trial.
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
Fonseca R, Bergsagel PL, Drach J, Shaughnessy J, Gutierrez N, Stewart AK, Morgan G, Van Ness B, Chesi M, Minvielle S, Neri A, Barlogie B, Kuehl WM, Liebisch P, Davies F, Chen-Kiang S, Durie BG, Carrasco R, Sezer O, Reiman T, Pilarski L, Avet-Loiseau H; International Myeloma Working Group. Fonseca R, et al. Among authors: chesi m. Leukemia. 2009 Dec;23(12):2210-21. doi: 10.1038/leu.2009.174. Epub 2009 Oct 1. Leukemia. 2009. PMID: 19798094 Free PMC article. Review.
91 results